Nuclear Stocks Worth Watching - April 13th

Key Points

• MarketBeat’s screener identifies seven nuclear stocks to watch: Oklo (OKLO), NuScale Power (SMR), BWX Technologies (BWXT), Centrus Energy (LEU), Nano Nuclear Energy (NNE), HCM II Acquisition (IMSR), and Karyopharm Therapeutics (KPTI).
• These names had the highest dollar trading volume among "nuclear" stocks recently and span reactor developers, fuel suppliers and component manufacturers, offering exposure to energy policy, uranium prices and electricity demand but carrying significant regulatory, safety and political risks that can drive volatility.
• Note: the list includes an outlier—Karyopharm is a pharmaceutical company focused on nuclear export proteins (XPO1), not nuclear energy—so investors should verify each firm's core business before investing.

Oklo, NuScale Power, BWX Technologies, Centrus Energy, Nano Nuclear Energy, HCM II Acquisition, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat's stock screener tool. "Nuclear stocks" are shares of companies whose primary business is tied to nuclear energy and the nuclear fuel cycle — for example, uranium miners, fuel processors, reactor and component manufacturers, engineering/construction firms, and utilities that operate nuclear power plants. Investors buy these stocks to gain exposure to trends in energy policy, electricity demand, and uranium prices, while bearing sector-specific regulatory, safety and political risks that can drive large price swings. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.

Oklo (OKLO)

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

Read Our Latest Research Report on OKLO

NuScale Power (SMR)

NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.

Read Our Latest Research Report on SMR

BWX Technologies (BWXT)

BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.

Read Our Latest Research Report on BWXT

Centrus Energy (LEU)

Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.

Read Our Latest Research Report on LEU

Nano Nuclear Energy (NNE)

Read Our Latest Research Report on NNE

HCM II Acquisition (IMSR)

Terrestrial Energy Inc. produces carbon free nuclear energy in North Carolina and internationally. The company was founded in 2013 and is headquartered in Charlotte, North Carolina.

Read Our Latest Research Report on IMSR

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).

Read Our Latest Research Report on KPTI

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.